BIOEUROPE SPRING

Without further delay, join Julie and Yassine to the event: https://informaconnect.com/bioeurope-spring/ and let’s schedule with them an e-meeting!

New ALGOGramTM session

The registration for the upcoming ALGOGramTM session is now open! A decision-making guide to accelerate your Pain programs.

Interactive brochure

Our new interactive brochure of services is now available! New brochure of services, new vision of the way we can support your R&D efforts! Good e-visit!  BROCHURE

Postoperative Pain

Surgical wounds-induced postoperative pain is our model of the month! The incisional pain model allows the assessment of the mechanisms of increased mechanical sensitivity following a surgical incision and is widely used for revealing the potency of new analgesics in this clinical situation.

Last call for ALGOGram

Lastcall for the next available #ALGOGram Winter session. Don’t miss it! √ A decision-making guide in developing the all-important product profile for your test compounds.

Stress-induced visceral hypersensitivity

Partial Restraint Stress-induced visceral hypersensitivity is our model of the month! Irritable bowel syndrome (IBS) is mainly characterized by abdominal pain impacting the quality of life. Various psychological stressors maybe responsible for the visceral hypersensitivity experienced by IBS patients.

Create a global reference

François Caussade, fondateur d’ANS Biotech, raconte son histoire, parmi 30 portraits d'entrepreneurs, dans le livre « We are Busi », une production de BUSI Incubateur, premier incubateur d’entreprises en France. Click here to access the full article.

ALGOGram™ Winter session

The registration for the upcoming ALGOGramTM Winter session is now open! A decision-making guide in developing the all-important product profile for your test compounds.

Diabetic Neuropathy

STZ-induced preclinical Diabetic neuropathy is our model of the month. Mechanical hyperalgesia and allodynia experienced by patients can be precisely mimicked and quantified.

Last call for ALGOGram™

Last call for the next available ALGOGram™ Fall session. Don’t miss it! √ A decision-making guide in developing the all-important product profile for your test compounds.

ISO 9001-2015 Certification

ANS Biotech has successfully renewed its ISO 9001-2015 certification. The company is ISO 9001 certified since 2014 and maintains every day the highest quality standards for its Customers’ satisfaction.

Preclinical Pruritus Model

5-HT-induced preclinical Pruritus model is our model of the month! The spontaneous behavior of scraping the injected area mimics itch situation experienced by patients”

ALGOGram™ Fall session

The registration for the upcoming ALGOGram™ Fall session is now open! √ A decision-making guide in developing the all-important product profile for your test compounds.

ANS Biotech appoints Dr. Philippe Genne to board of directors

ANS Biotech is very happy and proud to welcome Dr. Philippe Genne, President and CEO of Oncodesign, as new member of the board of directors. Click here to access to the entire press release.

Register Now for ANS Biotech webinar, September 17th

"Pharmacology and mechanisms of Oxaliplatin-induced neuropathic pain" by our CSO, Laurent DIOP. During this webinar, we will discuss: Clinical syndrome and diagnosis Mechanisms of CIPN Pharmacology and treatment Attendance is free, but registration is required. REGISTER NOW

Spared Nerve Injury

Spared Nerve Injury (SNI)-induced peripheral neuropathy pain is our model of the month! SNI model of peripheral mononeuropathy.

ALGOGram™ Back to School

The registration for the upcoming ALGOGram™ “Back to school” ! A decision-making guide in developing the all-important product profile for your test compounds.

Bone Cancer Pain

MRMT-1 Tumor cells-induced BCP is our model of the month! Bone is a privileged site of metastases for large primary tumors.

ANS Biotech Webinar

Save the date! Next ANS Biotech Webinar on September 17th, 2020. “Pharmacology and mechanisms of Oxaliplatin-induced neuropathic pain” by our CSO: Laurent Diop. Happy to share a valuable time with you!

ALGOGram™ Back to School

The registration for the upcoming ALGOGram™ “Back to school” session is now open! A decision-making guide in developing the all-important product profile for your test compounds.

AFFSI webinar: Last Recall

Final stretch for attending the next AFSSI's live webinar and learn more about ANSBiotech! Save the date for 02 JULY 2020 at 03:00 PM (CEST) and register now! Happy to share a valuable time with you!

Partial MNX-induced OA

Partial Meniscectomy-induced Osteoarthritis is our model of the month. Osteoarthritis is the most common form of the arthritis, affecting millions of people worldwide.

AFSSI Webinar : ANS Biotech

Attend the next AFSSI's live free webinar and learn more about ANS Biotech.   Save the date for 02JULY2020 at 03:00 PM (CEST) and register now.   Happy to share a valuable time with you!

Research Tax Credit (CIR) agreement

ANS Biotech announces the renewal of its Research Tax Credit (CIR) agreement for the 5 following years (2020-2024).

Last call for ALGOGram

Last call for the next available ALGOGram Session. Don’t miss it! A decision-making guide in developing the all-important product profile for your test compounds

New electronic barostat

As part of its growing capabilities in the field of visceral pain, ANS Biotech is now equipped with a second electronic barostat distender to support you research projects in this pain area.

Algogram™ Summer Session

Despite the current situation related to the COVID-19 pandemic, all the ANS Biotech Team is ready and proud to launch the ALGOGramTM Summer session! Registration is now open.

Continuity plan at ANS Biotech

Working from home or on site, all the pieces of the ANS Biotech puzzle stay strongly united and mobilized to pursue to proudly serve you.

NEW OXP model now available

We all need good news... Because good news is welcome, both in good times and bad, we are pleased to announce the launch of a new version of our model of Oxaliplatin-induced cold allodynia.

COVID-19

In the current global health context, ANS Biotech is mobilizing and adapting so as not to stop its support in the services for its Customers. We remain available online and fully mobilized for your projects.

ANS Biotech on the Science Exchange platform

We are pleased to announce that ANS Biotech is now an official registered vendor on the Science Exchange platform! Visit our Provider profile (https://www.scienceexchange.com/labs/ans-biotech) and easily start a collaboration with us!

Welcome to the SNI model

The arrival of the SNI model strengthens the already available offer of services in the field of traumatic neuropathic pain.

ANSbiosamples : New service with Oroxcell

ANS Biotech announces a collaborative agreement with Oroxcell for the bioanalyses of sampled fluids & tissues !

Experience the largest biotechnology event in the world

ANS Biotech will attend 2019 BIO International Convention, Philadelphia, PA, USA. Join us in Philadelphia, PA, June 3-6, 2019 as more than 16,000 attendees.

ANS Biotech explores pain

On Tuesday the 4th of December 2018, the local newspaper “La Montagne”, had an interview with the CEO, François Caussade. READ THE ARTICLE

17 th World Congress on Pain in Boston, MA (September 12-16, 2018)

ANS Biotech attended 17th World Congress on Pain in Boston, MA (September 12-16, 2018). ANS Biotech presented a poster titled: Comparison of the antinociceptive and antipruritic effects of kappa opioid receptor agonists on models of itch and pain.